Navigation Links
MaxWell Biocorporation, LLC, and International Medical Information Technologies, Inc., Announce Partnership
Date:8/1/2008

- Sponsorship Agreement Promotes International Medical Education, Helps

Break Down Language Barrier -

WASHINGTON, Aug. 1 /PRNewswire/ -- Russian-speaking medical professionals around the world have a potent new ally to help them integrate into the English-speaking mainstream of global medical research.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NETU078LOGO )

Dr. Peter M. Leitner, President of MaxWell USA, LLC, and Dr. Marina Filshtinsky, President of Boston-based International Medical Information Technologies, Inc. (IMIT) and editor-in-chief of MedMir.com, announced today a sponsorship deal between their two organizations.

MaxWell USA will provide the first significant outside funding received by IMIT since its 2005 inception. As a result, IMIT will be in a stronger position to supply timely, comprehensive, and free translations of leading medical journal articles to Russian-speaking medical professionals around the world.

By partnering, MaxWell and IMIT will contribute more effectively to improving the quality of healthcare offered by Russian-speaking medical providers to their patients wherever they may be.

About MedMir

MedMir.com (http://www.medmir.com) is the first project of the Boston-based nonprofit organization International Medical Information Technologies, Inc., IMIT (http://www.imithome.org). MedMir provides Russian-speaking medical professionals around the world with free access to timely, comprehensive, and accurate summaries of leading research papers from the world's top medical journals, translated by highly qualified medical specialists. The MedMir project began in January 2005 and has consistently attracted a growing number of Russian-speaking medical professional visitors to its website. MedMir is the only service on the Internet that provides timely, comprehensive international medical information in Russian. MedMir.com = World Medical Journal Reviews In Russian.

About MaxWell

MaxWell Biocorporation (http://www.max-well.com) is a U.S.-based, privately-held international medical and pharmaceutical company with wholly owned subsidiaries and affiliates in the United States and Ukraine dedicated to increasing life expectancy and improving the quality of life of people in Ukraine and other underserved emerging healthcare markets in the former Soviet Union. MaxWell targets oncological, cardiological, chronic infectious and autoimmune disorders and diseases through the development, production, and introduction into clinical practice of sophisticated, high quality, and affordable off-patent generic biopharmaceutical and chemopharmaceutical medicines and the latest diagnostic and therapeutic methods. MaxWell = "Maximum Wellness."

"We Help You Live Longer"

Contact:

Alex Meerovich

A.Meerovich@max-well.com

202-454-3403 Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Kenneth Alibek https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78826 Peter Leitner https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=78827


'/>"/>
SOURCE MaxWell Biocorporation, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. U.S. Commerce Secretary Gutierrez Cuts Ribbon on MaxWell Biocorporations New Pharmaceutical Development Center and Quality Control Laboratory in Ukraine
2. PURE Bioscience Announces DuraBan International as Distributor of SDC-Based Disinfectant
3. Geecf: Spectrum Blue Steel Announces Strategic Partnership with Al Manhal International Group of Abu Dhabi to Deploy Biosphere Facilities
4. Pharmasmart International Taps Top Executive Ashton Maaraba to Head Global Sales and Marketing
5. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
6. Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference
7. Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
8. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
9. Access Pharmaceuticals Presents New Data at International Symposium Showing Companys Angiolix(R) Monoclonal Antibody has Potential to Treat Cancer by Attacking Cancer Stem Cells
10. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
11. PAREXEL International Updates Earnings Guidance in Conjunction with Its Investor Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... 09, 2016 , ... The American Academy of Thermology (AAT) has ... 2016 AAT Member Certification Qualification Course for Technicians via a two part webinar on ... include a detailed review of hardware, software, and camera setup/operations, aligns with the in-person ...
(Date:2/9/2016)... HOUSTON , Feb. 9, 2016 /PRNewswire/ ... virus-driven immunotherapies for cancer, announced that its ... the European Commission as an orphan medicinal ... the deadliest form of glioma, strikes approximately ... and EU. http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
(Date:2/9/2016)... 2016 Three-Year Initiative Supports Next Generation ... Part in Life-Changing Camp Experiences ... positively affect the lives of children born with rare diseases, as ... SHPG ) is announcing a new initiative designed to positively affect ... the future of rare disease care. --> To mark ...
(Date:2/8/2016)... /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... clean technology companies in the TSX Venture 50 TM . ... on the TSX Venture Exchange, in each of five major ... & life sciences, diversified industries and technology – based ... on investment, market cap growth, trading volume and analyst coverage. ...
Breaking Biology Technology:
(Date:2/3/2016)... , Feb. 3, 2016 ... the addition of the "Emotion Detection ... Machine Learning, and Others), Software Tools (Facial ... Areas, End Users,and Regions - Global forecast ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has ...
(Date:2/2/2016)... , Feb. 2, 2016 This ... the bioinformatic market by reviewing the recent advances ... tools that drive the field forward. Includes forecast ... Identify the challenges and opportunities that exist ... and software solution developers, as well as IT ...
(Date:2/2/2016)... , Feb. 2, 2016 Technology Enhancements Accelerate ... an analysis of the digital and computed radiography markets ... , and Indonesia (TIM). ... and market size, as well as regional market drivers ... and discusses market penetration and market attractiveness, both for ...
Breaking Biology News(10 mins):